Perma-Fix Medical Schedules Business Update Conference Call
The conference call can be accessed via a live Internet webcast on the Company's website at www.medical-isotope.com. A webcast replay of the conference call will be accessible on the Company's website at www.medical-isotope.com for 90 days. If investors have any questions that they would like to pose to management please email firstname.lastname@example.org before 4:00 p.m. Central European Time on Thursday, May 22, 2014.
About Perma-Fix Medical
Perma-Fix Medical is a subsidiary of Perma-Fix Environmental Services, a NASDAQ listed company. It was formed to develop, obtain FDA and other regulatory approval and commercialize a new process to produce Technetium-99 (Tc-99m), the most widely used medical isotope in the world. The new process is expected to solve worldwide shortages of Tc-99m as it is less expensive, does not require the use of government-subsidized, weapons-grade materials and can be easily deployed around the world using standard research and commercial reactors, thereby eliminating the need for special purpose reactors.
David K. Waldman
Crescendo Communications, LLC
Tel : +1-212-671-1021
Dom Maklerski WDM S.A.
Tel: (+48 71) 79 11 555
Osoby reprezentujące emitenta
- Dominik Dymecki Prezes Zarządu